dm+d

Unassigned

New Medicines

Ewing sarcoma

Information

New molecular entity
ImmunityBio
ImmunityBio

Development and Regulatory status

None
None
Phase III Clinical Trials
Yes

Category

Human monoclonal antibody that binds to and inhibits insulin-like growth factor-1 receptor
Ewing’s sarcoma affects around 30 children per year in the UK. It is diagnosed in white Caucasians under the age of 25 at an incidence of 0.3/100,000 per year. It is very uncommon in the African and Asian population. The median age at diagnosis is 15 years and there is a male predilection of 1.5:1. The condition is extremely rare over the age of 40 [1].
Ewing sarcoma
Intravenous